These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23613721)

  • 1. Compliance to oseltamivir among two populations in Oxfordshire, United Kingdom affected by influenza A(H1N1)pdm09, November 2009--a waste water epidemiology study.
    Singer AC; Järhult JD; Grabic R; Khan GA; Fedorova G; Fick J; Lindberg RH; Bowes MJ; Olsen B; Söderström H
    PLoS One; 2013; 8(4):e60221. PubMed ID: 23613721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Degree of adherence to recommended antiviral treatment during the pandemic and post-pandemic periods of influenza A(H1N1)pdm09 in 148 intensive care units in Spain.
    Canadell L; Martín-Loeches I; Díaz E; Trefler S; Grau S; Yebenes JC; Almirall J; Olona M; Sureda F; Blanquer J; Rodriguez A;
    Med Intensiva; 2015 May; 39(4):222-33. PubMed ID: 25107582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oseltamivir-resistant pandemic (H1N1) 2009 virus infections, United States, 2010-11.
    Storms AD; Gubareva LV; Su S; Wheeling JT; Okomo-Adhiambo M; Pan CY; Reisdorf E; St George K; Myers R; Wotton JT; Robinson S; Leader B; Thompson M; Shannon M; Klimov A; Fry AM;
    Emerg Infect Dis; 2012 Feb; 18(2):308-11. PubMed ID: 22305467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging oseltamivir resistance in seasonal and pandemic influenza A/H1N1.
    Renaud C; Kuypers J; Englund JA
    J Clin Virol; 2011 Oct; 52(2):70-8. PubMed ID: 21684202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed emergence of oseltamivir-resistant seasonal influenza A (H1N1) and pandemic influenza A(H1N1)pdm09 viruses in Myanmar.
    Dapat C; Saito R; Kyaw Y; Myint YY; Oo HN; Oo KY; Naito M; Hasegawa G; Dapat IC; Suzuki H
    Influenza Other Respir Viruses; 2013 Sep; 7(5):766-71. PubMed ID: 23122276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oseltamivir-resistant pandemic (H1N1) 2009 virus, Mexico.
    Ramirez-Gonzalez JE; Gonzalez-Duran E; Alcantara-Perez P; Wong-Arambula C; Olivera-Diaz H; Cortez-Ortiz I; Barrera-Badillo G; Nguyen H; Gubareva L; Lopez-Martinez I; Díaz-Quiñonez JA; Lezana-Fernández MA; Gatell-Ramírez HL; Cordova Villalobos JA; Hernández-Avila M; Alpuche-Aranda C
    Emerg Infect Dis; 2011 Feb; 17(2):283-6. PubMed ID: 21291607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continued emergence and changing epidemiology of oseltamivir-resistant influenza A(H1N1)2009 virus, United Kingdom, winter 2010/11.
    Lackenby A; Moran Gilad J; Pebody R; Miah S; Calatayud L; Bolotin S; Vipond I; Muir P; Guiver M; McMenamin J; Reynolds A; Moore C; Gunson R; Thompson C; Galiano M; Bermingham A; Ellis J; Zambon M
    Euro Surveill; 2011 Feb; 16(5):. PubMed ID: 21315056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Environmental release of oseltamivir from a Norwegian sewage treatment plant during the 2009 influenza A (H1N1) pandemic.
    Leknes H; Sturtzel IE; Dye C
    Sci Total Environ; 2012 Jan; 414():632-8. PubMed ID: 22127154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of oseltamivir-resistant influenza A(H1N1)pdm09 viruses in Taiwan in 2009-2011.
    Yang JR; Huang YP; Chang FY; Hsu LC; Huang HY; Pan YT; Lin YC; Wu HS; Liu MT
    J Med Virol; 2013 Mar; 85(3):379-87. PubMed ID: 23280715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oseltamivir in seasonal, avian H5N1 and pandemic 2009 A/H1N1 influenza: pharmacokinetic and pharmacodynamic characteristics.
    Widmer N; Meylan P; Ivanyuk A; Aouri M; Decosterd LA; Buclin T
    Clin Pharmacokinet; 2010 Nov; 49(11):741-65. PubMed ID: 20923248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection of an influenza a (H1N1) pdm09 strain resistant to Oseltamivir in Peru].
    García J; Felices V; Gómez J; Gómez E; Laguna-Torres VA
    Rev Peru Med Exp Salud Publica; 2013 Mar; 30(1):157-8. PubMed ID: 23612841
    [No Abstract]   [Full Text] [Related]  

  • 12. Predicting Permissive Mutations That Improve the Fitness of A(H1N1)pdm09 Viruses Bearing the H275Y Neuraminidase Substitution.
    Farrukee R; Gunalan V; Maurer-Stroh S; Reading PC; Hurt AC
    J Virol; 2022 Aug; 96(15):e0091822. PubMed ID: 35867563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influenza A(H1N1)pdm09: beyond the pandemic.
    Viasus D; Antón A; Pumarola T; Carratalà J
    Enferm Infecc Microbiol Clin; 2012 Oct; 30 Suppl 4():54-7. PubMed ID: 23116794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The epidemiology and spread of drug resistant human influenza viruses.
    Hurt AC
    Curr Opin Virol; 2014 Oct; 8():22-9. PubMed ID: 24866471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oseltamivir boosts 2009 H1N1 virus infectivity in vitro.
    Lin X; Zhou J; Zhang Y; Wu J; Zhang F; Li Z; Zhang Y; Bi S; Shu Y; Wang Y
    Biochem Biophys Res Commun; 2009 Dec; 390(4):1305-8. PubMed ID: 19879239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency of oseltamivir resistance in Sydney, during the Newcastle outbreak of community transmitted oseltamivir-resistant influenza A(H1N1)pdm09 virus, Australia, June to August 2011.
    Wang B; Taylor J; Ratnamohan M; McPhie K; Kesson A; Dixit R; Booy R; Hurt A; Saksena N; Dwyer DE
    Euro Surveill; 2012 Jul; 17(27):. PubMed ID: 22790606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oseltamivir-resistant influenza A(H1N1)pdm09 virus associated with high case fatality, India 2015.
    Tandel K; Sharma S; Dash PK; Parida M
    J Med Virol; 2018 May; 90(5):836-843. PubMed ID: 29288584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral treatment and virological monitoring of oseltamivir-resistant influenza virus A(H1N1)pdm09 in a patient with chronic B lymphocytic leukemia.
    Salata C; Sgarabotto D; Del Vecchio C; Solimbergo E; Marini G; Nicolè S; Franchin E; Parolin C; Calistri A; Palù G
    J Infect Chemother; 2019 Jul; 25(7):543-546. PubMed ID: 31014561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oseltamivir storage, distribution and dispensing following the 2009 H1N1 influenza outbreak in Mexico.
    Gutiérrez-Mendoza LM; Schwartz B; Méndez de Lira Jde J; Wirtz VJ
    Bull World Health Organ; 2012 Oct; 90(10):782-7. PubMed ID: 23109746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors promoting the prolonged shedding of the pandemic (H1N1) 2009 influenza virus in patients treated with oseltamivir for 5 days.
    Ryoo SM; Kim WY; Sohn CH; Seo DW; Oh BJ; Lee JH; Lee YS; Lim KS
    Influenza Other Respir Viruses; 2013 Sep; 7(5):833-7. PubMed ID: 23279949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.